Whitehawk Therapeutics (WHWK) Interest Coverage Ratio (QoQ) (2010 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -31.37% |
| Jun 30, 2024 | 20.13% |
| Mar 31, 2024 | -8.25% |
| Dec 31, 2023 | -0.98% |
| Sep 30, 2023 | 8.68% |
| Jun 30, 2023 | -16.17% |
| Mar 31, 2023 | -6.87% |
| Dec 31, 2022 | -4.70% |
| Sep 30, 2022 | 18.10% |
| Jun 30, 2022 | -32.91% |
| Mar 31, 2022 | 14.86% |
| Dec 31, 2021 | 49.70% |
| Sep 30, 2021 | -3,157.79% |
| Jun 30, 2021 | 6.44% |
| Mar 31, 2021 | -161.66% |
| Dec 31, 2020 | 354.47% |
| Dec 31, 2016 | 34.06% |
| Sep 30, 2016 | -13.26% |
| Jun 30, 2016 | 2.01% |
| Mar 31, 2016 | -40,449.54% |
| Dec 31, 2015 | -119.51% |
| Sep 30, 2015 | 16.12% |
| Jun 30, 2015 | -10.03% |
| Mar 31, 2015 | 58.58% |
| Dec 31, 2014 | -80.17% |
| Sep 30, 2014 | 11.18% |
| Jun 30, 2014 | -26.92% |
| Mar 31, 2014 | 47.73% |
| Dec 31, 2013 | -80.82% |
| Sep 30, 2013 | 36.27% |
| Jun 30, 2013 | -10.36% |
| Mar 31, 2013 | 41.30% |
| Dec 31, 2012 | -76.09% |
| Sep 30, 2012 | 6.48% |
| Jun 30, 2012 | -5.73% |
| Mar 31, 2012 | 57.68% |
| Dec 31, 2011 | -47.65% |
| Sep 30, 2011 | 8.29% |
| Jun 30, 2011 | -35.88% |
| Mar 31, 2011 | 64.57% |
| Dec 31, 2010 | -69.26% |